← Back![Nuvaira Logo](/_next/image?url=https%3A%2F%2Fs3-us-west-2.amazonaws.com%2Fmedical-alley-association-data-interface%2FmemberLogos%2F62287.png%3F1722053134759&w=1080&q=75)
![Nuvaira Logo](/_next/image?url=https%3A%2F%2Fs3-us-west-2.amazonaws.com%2Fmedical-alley-association-data-interface%2FmemberLogos%2F62287.png%3F1722053134759&w=1080&q=75)
Partner
Medical Device
About this partner
Nuvaira, Inc. is a privately held medical device company that develops therapies to improve outcomes for patients suffering from obstructive lung diseases by addressing underlying disease pathophysiology. Specifically, the company has developed a novel, catheter-based system to treat overactive airway nerves, a common disease underpinning of both COPD and asthma, in a procedure called Targeted Lung Denervation (TLD). The dNerva® lung denervation system is CE Mark approved. The dNerva® lung denervation system is under clinical investigation and is not commercially available in the USA. Nuvaira and dNerva are trademarks of Nuvaira, Inc.
Related news